These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31371146)

  • 1. Clinical and electrophysiological characteristics of a type 1 sialidosis patient with a novel deletion mutation in NEU1 gene.
    Fan SP; Lee NC; Lin CH
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 3):406-412. PubMed ID: 31371146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 1 Sialidosis Patient With a Novel Deletion Mutation in the NEU1 Gene: Case Report and Literature Review.
    Ahn JH; Kim AR; Lee C; Kim NKD; Kim NS; Park WY; Kim M; Youn J; Cho JW; Kim JS
    Cerebellum; 2019 Jun; 18(3):659-664. PubMed ID: 30635863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I sialidosis, a normosomatic lysosomal disease, in the differential diagnosis of late-onset ataxia and myoclonus: An overview.
    Caciotti A; Melani F; Tonin R; Cellai L; Catarzi S; Procopio E; Chilleri C; Mavridou I; Michelakakis H; Fioravanti A; d'Azzo A; Guerrini R; Morrone A
    Mol Genet Metab; 2020 Feb; 129(2):47-58. PubMed ID: 31711734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal study of Taiwanese sialidosis type 1: an insight into the concept of cherry-red spot myoclonus syndrome.
    Lai SC; Chen RS; Wu Chou YH; Chang HC; Kao LY; Huang YZ; Weng YH; Chen JK; Hwu WL; Lu CS
    Eur J Neurol; 2009 Aug; 16(8):912-9. PubMed ID: 19473359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialidosis Type 1 with a Novel Mutation in the Neuraminidase-1 (NEU1) Gene.
    Gowda VK; Srinivasan VM; Benakappa N; Benakappa A
    Indian J Pediatr; 2017 May; 84(5):403-404. PubMed ID: 28138907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurophysiolgical implications in sialidosis type 1: a case report.
    Wang F; Lin L; Hu J; Zhang J; Wang K
    Int J Neurosci; 2022 Jun; 132(6):589-592. PubMed ID: 32988250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound heterozygous mutations in the neuraminidase 1 gene in type 1 sialidosis: A case report and review of literature.
    Cao LX; Liu Y; Song ZJ; Zhang BR; Long WY; Zhao GH
    World J Clin Cases; 2021 Jan; 9(3):623-631. PubMed ID: 33553400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathology of NEU1 gene in sialidosis.
    Seyrantepe V; Poupetova H; Froissart R; Zabot MT; Maire I; Pshezhetsky AV
    Hum Mutat; 2003 Nov; 22(5):343-52. PubMed ID: 14517945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygous structural variation mimicking homozygous missense mutations in NEU1 associated with presenting clinical signs in eyes alone.
    Li X; Zhang Q
    Ophthalmic Genet; 2020 Jun; 41(3):279-283. PubMed ID: 32270733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and clinical characterization of mainland Chinese patients with sialidosis type 1.
    Han X; Wu S; Wang M; Li H; Huang Y; Sui R
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1316. PubMed ID: 32453490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and serial MRI findings of a sialidosis type I patient with a novel missense mutation in the NEU1 gene.
    Sekijima Y; Nakamura K; Kishida D; Narita A; Adachi K; Ohno K; Nanba E; Ikeda S
    Intern Med; 2013; 52(1):119-24. PubMed ID: 23291686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Pathogenic Variant in the
    Sahoo LK; Kota V; Panigrahi PK; Pattnaik S; Mishra AP; Sahoo SK;
    Neurology; 2023 Nov; 101(19):861-862. PubMed ID: 37604664
    [No Abstract]   [Full Text] [Related]  

  • 13. First report of two Taiwanese siblings with sialidosis type I: a 10-year follow-up study.
    Chen CM; Lai SC; Chen IC; Hsu KC; Lyu RK; Ro LS; Chang HS
    J Neurol Sci; 2006 Aug; 247(1):65-9. PubMed ID: 16712870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multigene panel next generation sequencing in a patient with cherry red macular spot: Identification of two novel mutations in
    Mütze U; Bürger F; Hoffmann J; Tegetmeyer H; Heichel J; Nickel P; Lemke JR; Syrbe S; Beblo S
    Mol Genet Metab Rep; 2017 Mar; 10():1-4. PubMed ID: 27942463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico identification of new putative pathogenic variants in the NEU1 sialidase gene affecting enzyme function and subcellular localization.
    Bonardi D; Ravasio V; Borsani G; d'Azzo A; Bresciani R; Monti E; Giacopuzzi E
    PLoS One; 2014; 9(8):e104229. PubMed ID: 25153125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex.
    Lukong KE; Elsliger MA; Chang Y; Richard C; Thomas G; Carey W; Tylki-Szymanska A; Czartoryska B; Buchholz T; Criado GR; Palmeri S; Pshezhetsky AV
    Hum Mol Genet; 2000 Apr; 9(7):1075-85. PubMed ID: 10767332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Structural Characteristics of NEU1 Variants Causing Sialidosis Type 1.
    Li Y; Liu Y; Wang R; Ao R; Xiang F; Zhang X; Wang X; Yu S
    J Mov Disord; 2024 Jul; 17(3):282-293. PubMed ID: 38600684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infantile sialidosis: natural history in a preterm infant with two new pathogenic mutations and new ocular findings.
    Pérez-Cabeza MI; Borrás F; Moreno-Medinilla EE; Bardán-Rebollar D; Ferrer-López I; Rodríguez-García E; Jiménez-Machado R; Castro-Vega I; Benito C; Escudero J; Yahyaoui R
    J AAPOS; 2019 Apr; 23(2):102-104. PubMed ID: 30445145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding sialidosis spectrum by genome-wide screening: NEU1 mutations in adult-onset myoclonus.
    Canafoglia L; Robbiano A; Pareyson D; Panzica F; Nanetti L; Giovagnoli AR; Venerando A; Gellera C; Franceschetti S; Zara F
    Neurology; 2014 Jun; 82(22):2003-6. PubMed ID: 24808020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling Sialidosis with Neural Precursor Cells Derived from Patient-Derived Induced Pluripotent Stem Cells.
    Seol B; Kim YD; Cho YS
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.